drugset / Trial / NCT02207946
Botulinum Toxin A to Treat Arm Tremor
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to assess the efficacy and safety of a single, kinematic-analysis-based intramuscular injection of NT 201, compared with placebo, in moderate to marked essential tremor of the upper limb.
Timeline
- Start
- 2014-12-05
- Primary completion
- 2016-05-09
- Completion
- 2016-09-26
Outcome
Missed primary endpoint
registry analysis (superiority test); IncobotulinumtoxinA 30 to 200 U vs Placebo; p = 0.144; LS mean difference -0.43 (95% CI -1.02 to 0.16); ANCOVA NCT02207946 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Intramuscular |